Annual Conference 2018

230 - A Treatment Option for Castration-Resistant Prostate Cancer (CRPC)

Oct 27, 2018 12:15pm ‐ Oct 27, 2018 1:30pm


Description

Sponsored by Astellas Pharma US, Inc. and Pfizer Oncology

Speaker(s):

You must be logged in and own this session in order to post comments.